CorMedix Inc
Avatud
SektorTervishoid
7.94 -1.85
Ülevaade
Aktsiahinna muutus
24h
Min
7.92
Max
8.14
Sissetulek | -77M -39M |
|---|---|
Müük | -25M 102M |
P/E Sektori keskmine | 3.867 56.597 |
Aktsiakasum | 0.29 |
Kasumimarginaal | -37.87 |
Töötajad | 191 |
EBITDA | -8.8M 57M |
Järgmine tulemuste avaldamine | 11. nov 2026 |
|---|
Turukapital | 66M 657M |
|---|---|
Eelmine avamishind | 9.79 |
Eelmine sulgemishind | 7.94 |
Uudiste sentiment
By Acuity
44%
56%
132 / 339 Pingereas Healthcare
CorMedix Inc Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Seotud uudised
Võrdlus sarnastega
Hinnamuutus
CorMedix Inc Prognoos
Sentiment
By Acuity
132 / 339 Pingereas Tervishoid
Uudiste sentiment
Languse märgid
Volatiilsus
Alla keskmise
Uudismaht (RCV)
Alla keskmise
Finantsandmed
Müügi- ja halduskulud
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
Intressikulud võla pealt
EBITDA
Ärikasum
$
Ettevõttest CorMedix Inc
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.